Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

WVE

Wave Life Sciences Ltd.

Oct 16 • 12:11PM ET

15.05

Dollar change +6.49
Percentage change 75.82	%

Healthcare • Biotechnology • Singapore • NASD

Peers: IONS ALNY SRPT ARWR MRNA NBIX VRTX BIIB QURE EDIT

| Held by: IWM VXF IBB IWO SCHA KOMP VTWO IWC VHT XPH

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.58	Insider Own	22.47%	Shs Outstand	154.93M	Perf Week	78.96%
Market Cap	2.33B	Forward P/E	-	EPS next Y	-1.00	Insider Trans	8.50%	Shs Float	120.11M	Perf Month	163.58%
Income	-73.74M	PEG	-	EPS next Q	-0.29	Inst Own	65.24%	Short Float	4.66%	Perf Quarter	162.66%
Sales	110.50M	P/S	21.10	EPS this Y	-93.00%	Inst Trans	16.63%	Short Ratio	4.57	Perf Half Y	214.20%
Book/sh	-0.03	P/B	-	EPS next Y	3.94%	ROA	-33.61%	Short Interest	5.59M	Perf Year	169.24%
Cash/sh	0.99	P/C	15.15	EPS next 5Y	-	ROE	-1928.16%	52W Range	3.50 - 9.92	Perf YTD	198.03%
Dividend Est.	-	P/FCF	-	EPS past 5Y	36.03%	ROI	-282.45%	52W High	51.72%	Beta	-1.12
Dividend TTM	-	Quick Ratio	0.99	Sales past 5Y	610.91%	Gross Margin	92.04%	52W Low	330.01%	ATR (14)	0.98
Dividend Ex-Date	-	Current Ratio	0.99	EPS Y/Y TTM	56.96%	Oper. Margin	-75.74%	RSI (14)	85.10	Volatility	5.22% 7.95%
Employees	268	Debt/Eq	6.56	Sales Y/Y TTM	202.25%	Profit Margin	-66.73%	Recom	1.30	Target Price	15.90
Option/Short	Yes / Yes	LT Debt/Eq	4.93	EPS Q/Q	-27.04%	Payout	-	Rel Volume	23.51	Prev Close	8.56
Sales Surprise	1.23%	EPS Surprise	-20.54%	Sales Q/Q	-10.92%	Earnings	Aug 08 BMO	Avg Volume	1.22M	Price	15.05
SMA20	80.93%	SMA50	123.60%	SMA200	160.59%	Trades		Volume	12,721,074	Change	75.82%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-27-24	Resumed	JP Morgan	Overweight	$10 → $13
Sep-19-24	Initiated	B. Riley Securities	Buy	$11
Sep-09-24	Initiated	JP Morgan	Overweight	$10
May-15-24	Initiated	Wells Fargo	Overweight	$11
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform	$5 → $12
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5
Dec-15-20	Resumed	H.C. Wainwright	Buy	$20
Oct-23-20	Initiated	RBC Capital Mkts	Sector Perform	$13
Dec-31-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$33 → $10
Nov-01-19	Initiated	Guggenheim	Buy	$43
Jul-15-19	Initiated	Cowen	Market Perform
Apr-17-19	Reiterated	H.C. Wainwright	Buy	$49 → $33
Aug-07-18	Initiated	Stifel	Buy	$56
Jul-23-18	Initiated	H.C. Wainwright	Buy	$49
Mar-19-18	Reiterated	Mizuho	Buy	$34 → $65
Feb-15-17	Initiated	H.C. Wainwright	Buy	$41
Nov-10-16	Resumed	Leerink Partners	Outperform
Dec-07-15	Initiated	Sun Trust Rbsn Humphrey	Buy	$26
Dec-07-15	Initiated	Leerink Partners	Outperform	$20

Show Previous Ratings

Today 11:39AM	Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed. (Investor's Business Daily) +75.82%
08:44AM	Wave Life Sciences (WVE): Advancing Gene Therapy for Duchenne Muscular Dystrophy (Insider Monkey)
08:30AM	Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
08:25AM	Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024 (GlobeNewswire)
Oct-11-24 11:56AM	GSK Bought More Shares of Biotech Wave Life Sciences (Barrons.com)
09:55AM	Loading…
09:55AM	How Much Upside is Left in Wave Life Sciences (WVE)? Wall Street Analysts Think 89.71% (Zacks)
Oct-09-24 05:36PM	WAVE Life Sciences Ltd (WVE) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Rising ... (GuruFocus.com) +5.12%
Oct-03-24 08:15AM	Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics (Motley Fool)
Oct-01-24 09:20AM	Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Sep-30-24 08:30AM	Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-25-24 09:14PM	Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +10.01% -10.99%
06:32AM	Waves stock swells as it eyes approval following Phase II DMD victory (Clinical Trials Arena)
Sep-24-24 04:01PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +53.37%
11:19AM	Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug (Benzinga)
07:30AM	Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping (GlobeNewswire)
01:17AM	Loading…
Aug-24-24 01:17AM	Insider Selling: President and CEO Paul Bolno Sells 48,366 Shares of WAVE Life Sciences Ltd (WVE) (GuruFocus.com)
Aug-12-24 08:30AM	Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy (GlobeNewswire)
Aug-08-24 08:45AM	Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:47AM	Wave Life Sciences: Q2 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-24 08:30AM	Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024 (GlobeNewswire) -6.81%
Jun-25-24 07:30AM	Wave, with new data, plots path forward for Huntingtons drug (BioPharma Dive) -8.45%
07:30AM	Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington's Disease (GlobeNewswire)
Jun-12-24 08:30AM	Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing (GlobeNewswire)
May-30-24 08:30AM	Wave Life Sciences to Present at 2024 Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 07:16AM	Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target (MT Newswires)
May-10-24 04:53PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:39PM	WAVE Life Sciences Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-09-24 07:45AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
07:00AM	Loading…
07:00AM	Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer (GlobeNewswire)
May-07-24 08:30AM	Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-02-24 08:30AM	Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024 (GlobeNewswire)
Apr-30-24 08:30AM	Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) (GlobeNewswire)
Apr-23-24 08:30AM	Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing (GlobeNewswire)
Mar-27-24 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire) +6.71%
Mar-15-24 08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Mar-07-24 10:47AM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2023 Earnings Call Transcript (Insider Monkey) +8.43%
Mar-06-24 12:51PM	WVE Stock Earnings: WAVE Life Sciences Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) +31.32%
07:51AM	Wave Life Sciences: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-28-24 08:30AM	Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024 (GlobeNewswire)
04:16AM	Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains? (Zacks)
Feb-27-24 08:30AM	Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire) +10.87%
Feb-06-24 01:17PM	Hedge Fund and Insider Trading News: John Paulson, Dan Loeb, Millennium Management, Wave Life Sciences Ltd. (WVE), Super Micro Computer Inc (SMCI), and More (Insider Monkey)
Jan-31-24 01:21PM	Hedge Fund and Insider Trading News: Ken Griffin, Seth Klarman, Millennium Management, Wave Life Sciences Ltd. (WVE), Columbia Banking System Inc (COLB), and More (Insider Monkey)
Jan-08-24 08:00AM	Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones (GlobeNewswire) +5.06%
Jan-03-24 08:30AM	Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-23 08:30AM	Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire)
Dec-07-23 07:00AM	Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares (GlobeNewswire) -30.42%
Dec-06-23 04:10PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +9.22%
04:08PM	Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Nov-22-23 08:30AM	Wave Life Sciences to Present at 6 Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-11-23 12:09PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:38AM	WAVE Life Sciences Ltd (WVE) Reports Notable Shift to Profitability in Q3 2023 (GuruFocus.com) -9.55%
07:43AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-03-23 04:05PM	Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023 (GlobeNewswire) +6.02%
Sep-29-23 05:47AM	Wave Life Sciences (WVE) Soars 8.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-28-23 04:15PM	Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day (GlobeNewswire) +8.71%
Sep-25-23 08:30AM	Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-06-23 08:30AM	Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Sep-05-23 07:30AM	Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual R&D Day (GlobeNewswire)
Aug-23-23 11:13AM	WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months (GuruFocus.com) +6.99%
Aug-17-23 08:44AM	11 Best Biotech Penny Stocks to Buy Now (Insider Monkey)
06:40AM	7 A-Rated Biotech Stocks for Your August Buy List (InvestorPlace)
Aug-10-23 12:40PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 06:02AM	Analyst Forecasts For Wave Life Sciences Ltd. (NASDAQ:WVE) Are Surging Higher (Simply Wall St.)
Aug-04-23 06:45AM	Wave Life Sciences Ltd.'s (NASDAQ:WVE) 42% Price Boost Is Out Of Tune With Revenues (Simply Wall St.)
Aug-03-23 08:55AM	Wave Life Sciences (WVE) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +15.79%
07:53AM	Wave Life Sciences: Q2 Earnings Snapshot (AP Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-27-23 08:30AM	Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023 (GlobeNewswire)
Jul-06-23 08:40AM	Wave Life Sciences (NASDAQ:WVE) shareholders have endured a 90% loss from investing in the stock five years ago (Simply Wall St.)
Jun-26-23 08:30AM	Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
Jun-19-23 08:00AM	Top Penny Stocks for Q3 2023 (Investopedia)
May-23-23 07:30AM	Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (GlobeNewswire)
May-16-23 08:30AM	Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting (GlobeNewswire) -7.94%
May-08-23 06:03AM	The Consensus EPS Estimates For Wave Life Sciences Ltd. (NASDAQ:WVE) Just Fell Dramatically (Simply Wall St.)
May-05-23 06:19AM	Wave Life Sciences First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.) +9.32%
May-03-23 08:55AM	Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:49AM	Wave Life Sciences: Q1 Earnings Snapshot (AP Finance)
07:30AM	Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-26-23 08:30AM	Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023 (GlobeNewswire)
Apr-20-23 08:30AM	Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry (GlobeNewswire)
Mar-29-23 08:54AM	Can Wave Life Sciences (NASDAQ:WVE) Afford To Invest In Growth? (Simply Wall St.) +8.48%
08:00AM	Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days (GlobeNewswire)
Mar-24-23 07:36AM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.04%
Mar-22-23 08:45AM	Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -10.38%
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-02-23 08:30AM	Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 (GlobeNewswire)
Feb-14-23 12:00PM	Wave Life Sciences (WVE) Upgraded to Buy: Here's What You Should Know (Zacks)
09:35AM	After Plunging -23.26% in 4 Weeks, Here's Why the Trend Might Reverse for Wave Life Sciences (WVE) (Zacks)
Feb-09-23 04:05PM	Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference (GlobeNewswire) -8.81%
Jan-25-23 06:06AM	Wave Life Sciences (NASDAQ:WVE) shareholders have earned a 115% return over the last year (Simply Wall St.)
Jan-13-23 07:26AM	Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains? (Zacks)
Jan-03-23 05:40AM	The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences (Zacks) -11.43%
Dec-30-22 12:00PM	All You Need to Know About Wave Life Sciences (WVE) Rating Upgrade to Buy (Zacks)
09:03AM	4 Drug Stocks That More Than Doubled This Year (Zacks)
Dec-19-22 01:04PM	Wave Life Sciences Touts Encouraging Data From Duchenne Muscular Dystrophy Study (Benzinga)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Moran Kyle	Chief Financial Officer	Oct 11 '24	Option Exercise	2.48	25,000	62,000	44,777	Oct 11 08:00 PM
GSK plc	10% Owner	Sep 27 '24	Buy	8.00	2,791,930	22,335,440	16,775,691	Oct 01 05:54 PM
Moran Kyle	Chief Financial Officer	Sep 25 '24	Sale	9.00	17,146	154,314	19,777	Sep 27 08:00 PM
KYLE MORAN	Officer	Sep 25 '24	Proposed Sale	9.00	17,146	154,314		Sep 25 09:40 PM
BOLNO PAUL	President and CEO	Aug 21 '24	Sale	5.78	48,366	279,555	359,059	Aug 23 06:00 PM
PAUL BOLNO	Officer	Aug 21 '24	Proposed Sale	5.78	48,366	279,638		Aug 21 04:24 PM
Vargeese Chandra	See Remarks	Jul 22 '24	Option Exercise	2.48	68,210	169,161	185,061	Jul 24 05:54 PM
Moran Kyle	Chief Financial Officer	Apr 03 '24	Sale	6.17	15,630	96,421	33,921	Apr 05 08:00 PM
GSK plc	10% Owner	Dec 07 '23	Buy	5.00	3,300,000	16,500,000	13,983,761	Jan 30 04:39 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Dec 11 '23	Buy	5.00	1,000,000	5,000,000	19,202,009	Dec 13 04:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

WVE

Wave Life Sciences Ltd.

Upgrade your FINVIZ experience